FMC Board Authorizes Exploring Sale; 2026 Adjusted EBITDA Guided Down 17%
FMC reported fourth quarter and full year 2025 results with a large GAAP loss driven by a non-cash goodwill impairment, and gave 2026 guidance showing lower revenue, EBITDA and adjusted EPS. The Board has also authorized exploration of strategic options, including a possible sale of the company, but the company says the review is preliminary and may not result in any transaction.
Key points
- Board authorized exploration of strategic options, including but not limited to the sale of the company; no assurance a transaction will result
- 2026 guidance: revenue $3.60 billion to $3.80 billion (down 5% at midpoint); adjusted EBITDA $670 million to $730 million (down 17%); adjusted EPS $1.63 to $1.89 (down 41%)
- Q4 2025 GAAP net loss of $1.72 billion, or $13.74 per diluted share, driven mainly by a $1,356.2 million goodwill write-off
- Full year 2025 revenue of $3.47 billion, down 18%; adjusted EPS of $2.96, down 15%
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.